Linkedin Facebook Twitter Youtube

08 Oct Evia Bio

Posted at 18:01h in by

Allison Hubel, Ph.D., Chief Scientific Officer

Oct. 7 | 5:45pm | FLW Ballroom G

Minneapolis, MN

(Private)

Evia Bio is a life sciences tools and services company dedicated to delivering better and safer therapeutics for the Cell and Gene Therapy community. Evia Bio offers Cryo Engineering Services to help assess and optimize cryopreservation protocols and solutions for CDMOs and cell therapy developers. Evia is also developing and commercializing DMSO-free and DMSO-minimized solutions to mitigate toxicity and improve post-thaw performance while reducing manufacturing complexities and patient risk. Evia Bio was founded by leading cryobiologist Allison Hubel, PhD. We are actively partnering with cell therapy leaders to reduce DMSO, improve therapeutic efficacy, and establish robust cryopreservation processes.

www.eviabio.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,500 attendees – over 30% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 5-7, 2026
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions